Monroid takes the helm at Euro&s Metamax

Share this article:

Euro RSCG Life announced it has hired Cline, Davis & Mann's Julie Monroid to head its MetaMax unit (as first reported in the MM&M Agency Issue, July 2007), which is responsible for much of its Sanofi-Aventis business.

Monroid, who was SVP, group managing director at CDM, becomes EVP, managing director of MetaMax, reporting to MetaMax president and North American co-CEO Doug Burcin. At CDM, she led sizable accounts on Pfizer's Viagra and Relpax and Novo Nordisk's Levemir, NovoLog Mix 70/30, NovoLog and FlexPen -- experience sure to come in handy on Sanofi-Aventis' diabetes drugs Lantus and Lovenox, for which MetaMax handles professional advertising.

Euro RSCG Life reorganized its senior leadership in the spring, following the retirement of chairman Ron Pantello and the departure of CEO Jim Metropoulos, who left just several months after the HAVAS network hired him away from Sudler & Hennessey.

Share this article:

Email Newsletters

More in News

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.

Five things for pharma marketers to know: Thursday, August 21

Five things for pharma marketers to know: Thursday, ...

An Ebola survivor is set to leave Emory University Hospital, but the cause of the cure is uncertain, the FDA has approved a new type 1 diabetes test, and the ...